MREO vs ROP · $48.7M cap vs P/E 41, rev $4.20B
Mereo BioPharma Group PLC ADR (MREO) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
MREO currently screens at market cap $48.7M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the MREO and ROP stock pages for the full models.
Not investment advice.